Tuesday, 26 May 2020


Taiwan finds genetic marker for pancreatic cancer

30 October 2013 | News | By BioSpectrum Bureau

National Health Research Institute, Taiwan, also finds that 80 percent of pancreatic cancer patients, who do have an operation, die from relapse within five years

National Health Research Institute, Taiwan, also finds that 80 percent of pancreatic cancer patients, who do have an operation, die from relapse within five years

Singapore: Scientists at the National Health Research Institute of Taiwan have discovered genetic markers that can predict the likelihood of surviving pancreatic cancer.

According to the NHRI, only about 20 percent of sufferers are diagnosed at a stage where localized surgery is feasible, and more than 80 percent who do have an operation die from relapse within five years.

The discovery of genetic markers linked to prognosis creates possibilities for patient-specific chemotherapy or other targeted interventions.

 


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account